("Quid coniuratio est?")
AIDS Inc. -- Part 6
+ + + + + + + + + + + + + + + + + + + + + +
"In Europe, the question of whether AIDS could have been made in a lab is much more seriously entertained than in the United States."
However, to suggest that AIDS came only from a lab is to reject the multifactorial model. This does not rule out some AIDS cases being traceable to the lab, but those who believe that AIDS originated entirely in the lab have bought "the principal party line about AIDS, hook, line, and sinker."
Still, "whether or not CBW [Chemical Biological Warfare] has brought forth germs and chemicals which have caused various forms of immunosuppression -- that is a very reasonable question. It is also very difficult to answer because... the types of accidents which have occurred at [CBW] facilities, and even the types of microbes worked with, are secret."
[Two good books dealing with CBW "incidents" are A Higher Form of Killing (Paxman and Harris, Hill and Wang publishers, 1982) and Gene Wars (Piller and Yamamoto, William Morrow and Company, 1988).]
Not only is it quite possible that some so-called AIDS symptoms can be traced to Chemical Biological Warfare [CBW] agents, but at least as important is that "we have a whole industry here which is out of the public view, which has done some very nasty things, which has never been opened for serious government inspection. To say nothing of public inspection. In the area of CBW, two very unpleasant strains of human attitude come together: military secrecy and the arrogance of 'doctor knows best.'"
The author, Jon Rappoport, proceeds to give examples of the irresponsible and possibly dangerous acts which those in charge of CBW have sanctioned. For example, "In 1977, it was revealed that the U.S. Army had performed 239 secret biological tests in the U.S. between 1949-1969. Example: In 1965, 'biological agents' were spread around at a Greyhound bus terminal in Washington D.C. This routine was repeated in 1968 in a New York City subway station."
A 1987 article in the Covert Action Information Bulletin (Number 28) entitled "Precedents for AIDS?" summarizes a series of tests done on prisoners: "From 1965 to 1968, 70 prisoners, mostly black, at Holmesburg State Prison in Philadelphia, were the subjects of tests by Dow Chemical Company of the effects of dioxin... Their skins were deliberately exposed to large doses and then monitored to watch the results." No follow-up was done on subjects for possible development of cancer.
"In recent years, there have been several allegations of biowarfare. U.S. intelligence agencies claim an outbreak of anthrax in the Soviet city of Sverdlovsk, in the Spring of 1979, was the outcome of a leak from a suspected CBW lab there." The death toll from that incident is estimated at between 40 to 1000 people.
"The U.S.S.R. states that in 1984, the U.S., in a Brazilian deforestation program, killed 7000 Indians and caused many birth defects, through the use of chemical herbicides."
In their book A Higher Form of Killing, authors Paxman and Harris quote from a comment made in 1969 before a House Committee by a Dr. Leonard MacArthur: "Within the next 5 to 10 years, it would probably be possible to make a new infective microorganism which could differ in certain important respects from any known disease-causing organisms. Most important of these is that it might be refractory to the immunological and therapeutic processes upon which we depend to maintain our relative freedom from infectious disease."
An article in the November 1970 issue of Military Review by geneticist Carl Larson pointed out the possibility of designing chemicals to attack specific groups. Larson believed that "observed variations in drug response have pointed to the possibility of great innate differences in vulnerability to chemical agents between different populations."
Universities work hand in hand with the Pentagon in conducting elements of CBW research. Between 1967 and 1988, the list of universities holding CBW contracts with the Pentagon has not diminished but rather has increased. In addition, the amount of money allocated to CBW research has also increased. "During the last eight years, the official CBW budget has grown to about $100 million a year."
"Indicating that as of 1987, 127 sites around the U.S. were doing CBW research, including universities, foundations, and private corporations, a Science report (Feb. 27, 1987) stated: 'The Department of Defense is applying recombinant DNA techniques in research and the production of a range of pathogens and toxins, including botulism, anthrax, and yellow fever.'"
"What are the chances that an independent scientific group would investigate the CBW industry to see if some of its microbes had been involved in causing any part of what is being called AIDS? The chances would be about zero, just as the chances would be about zero of investigating animal research centers all over the world -- without major public pressure."
The January, 1988 issue of The Atlantic reports on the recent rise in new syphilis cases. In an article entitled "AIDS and Syphilis," the author (Katie Leishman) reports the following: 1) Much syphilis today goes unnoticed, or is misdiagnosed. 2) Syphilis is often treated with inadequate doses of penicillin. 3) Disproportionately large numbers of syphilis cases, in the
last ten years, have occurred in the U.S. male gay and IV
4) The dementia associated with AIDS may be late-stage
5) There is an overlap of symptoms between AIDS and syphilis.
"Nitrite inhalants may rank at the top of the list of relevant factors in Kaposi's sarcoma, but syphilis may be involved too." In his book entitled AIDS and Syphilis, the Hidden Link, author Harris Coulter points out (among other things) that Kaposi's sarcoma and syphilis share certain traits.
"Coulter concludes that the disappearance of syphilis in the U.S. during the 1950s was achieved 'by antibiotic abuse, suppressing the disease (instead of knocking it out) and causing it to smoulder away like an underground fire. It has slowly burned out the immune systems of a large proportion of those who have been (poorly) treated.'"
"Dr. Stephen Caiazza, a New York physician, has been treating AIDS patients for syphilis. For the past year [ca. 1988], he has combined a regimen of penicillin and doxycycline, and out of 125- 150 patients, he reports only one has died."
What follows are excerpts from an interview which Jon Rappoport conducted with Dr. Caiazza, on March 21, 1988:
INTERVIEWER: What made you originally suspect that some people diagnosed with AIDS actually had syphilis?
DR. CAIAZZA: I wasn't seeing any syphilis in my gay patients. I was treating them for every other kind of STD [Sexually Transmitted Disease]. So I said, where is the syphilis?
INTERVIEWER: The tests weren't showing it.
DR. CAIAZZA: The tests are totally inadequate.
INTERVIEWER: Your patients -- these 125 -- are really better?
DR. CAIAZZA: Absolutely. By bloodwork and by clinical symptoms. We naturally watch both factors. They become able to work, to come to the office unassisted and to do things that require energy. Their T and B-cells improve too, slowly, but they improve.
INTERVIEWER: Is this your only treatment, the penicillin and then the doxycycline?
DR. CAIAZZA: Nutrition is very important. If the patient isn't getting what he needs, the drugs aren't going to work. For example, let's say he had been doing poppers. That binds up vitamin B-12, so he can't utilize it. In that case, his immune system just isn't going to produce.
INTERVIEWER: Are there other physicians in the U.S. who are replicating your results with their patients?
DR. CAIAZZA: None have been doing it long enough, but I'm happy to say a few are starting out with this regimen. I'm getting a grass roots response from doctors and patients.
INTERVIEWER: What has been the response of "health authorities?"
DR. CAIAZZA: Zero. I've talked to a number of officials in New York, both city and state, and they aren't interested at all.
INTERVIEWER: And what about the CDC and NIH?
DR. CAIAZZA: Are you kidding? All the research money that's available for AIDS is going to the retrovirologists.
INTERVIEWER: Prior to treating your AIDS patients for syphilis, what were you doing?
DR. CAIAZZA: From 1983 to 1986, I was just another doctor handling AIDS cases, doing the usual treatments, the best ones that were available. Many of those people died. About one a week. Now, in the last year, one has died. I mean, I can't believe it.
INTERVIEWER: Obviously, there would be no economic payoff for the medical industry if your approach were to win out.
DR. CAIAZZA: Certainly not for the pharmaceutical houses. This treatment is cheap.
[...to be continued...]
I encourage distribution of "Conspiracy Nation."
See also: http://www.europa.com/~johnlf/cn.html
See also: ftp ftp.shout.net pub/users/bigred